Literature DB >> 26114228

Depression rating scales in Parkinson's disease: A critical review updating recent literature.

Elizabeth Torbey1, Nancy A Pachana2, Nadeeka N W Dissanayaka3.   

Abstract

Depression is a prominent non-motor symptom in Parkinson's disease (PD). Assessing depression in PD remains a challenge due to the overlap of somatic symptoms between depression and PD. Other neuropsychiatric manifestations associated with PD, such as cognitive decline, also complicate assessment of depression. Therefore it is critical to investigate the validity of depression rating scales for use in PD. This will allow evaluation of observer- and self-report instruments to be administered in neurologically ill geriatric populations such as PD, and identification of appropriate scales to use in cognitively challenged PD patients. The present review includes all studies examining the validity of depression rating scales in PD. It discusses the usefulness of 13 depression rating scales in PD. The clinician-rated and widely used HAMD-17 and the self-report GDS scales are recommended for screening and measuring severity of depression in PD. The GDS-15 may be a preferred choice due to its brevity and ease of use design for older adults. Other valid and reliable instruments to use in PD include self-rated scales, such as the HADS-D, HDI, and the BDI, and the observer-report, MADRS. The CSDD displayed satisfactory validity and reliability for identification of PD patients with and without dementia. The PHQ-2, PHQ-10, SDS, CES-D, UPDRS-Depression item, IDS-SR, and IDS-C each showed some evidence of validity or reliability, however further research on the psychometric properties of these scales when used in a PD population are required.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Depression; Parkinson's disease; Rating scales; Review

Mesh:

Year:  2015        PMID: 26114228     DOI: 10.1016/j.jad.2015.05.059

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  24 in total

Review 1.  Detecting depression in Parkinson disease: A systematic review and meta-analysis.

Authors:  Zahra Goodarzi; Kelly J Mrklas; Derek J Roberts; Nathalie Jette; Tamara Pringsheim; Jayna Holroyd-Leduc
Journal:  Neurology       Date:  2016-06-29       Impact factor: 9.910

2.  Unilateral ultra-brief pulse electroconvulsive therapy for depression in Parkinson's disease.

Authors:  N R Williams; B S Bentzley; G L Sahlem; J Pannu; J E Korte; G Revuelta; E B Short; M S George
Journal:  Acta Neurol Scand       Date:  2016-05-31       Impact factor: 3.209

3.  MPP+-Lesioned Mice: an Experimental Model of Motor, Emotional, Memory/Learning, and Striatal Neurochemical Dysfunctions.

Authors:  Mauricio P Cunha; Francis L Pazini; Vicente Lieberknecht; Josiane Budni; Ágatha Oliveira; Júlia M Rosa; Gianni Mancini; Leidiane Mazzardo; André R Colla; Marina C Leite; Adair R S Santos; Daniel F Martins; Andreza F de Bem; Carlos Alberto S Gonçalves; Marcelo Farina; Ana Lúcia S Rodrigues
Journal:  Mol Neurobiol       Date:  2016-10-08       Impact factor: 5.590

4.  What does the Dementia Rating Scale-2 measure? The relationship of neuropsychological measures to DRS-2 total and subscale scores in non-demented individuals with Parkinson's disease.

Authors:  Francesca V Lopez; Lauren E Kenney; Adrianna Ratajska; Charles E Jacobson; Dawn Bowers
Journal:  Clin Neuropsychol       Date:  2021-11-15       Impact factor: 4.373

Review 5.  "Pseudo-syndromes" associated with Parkinson disease, dementia, apathy, anxiety, and depression.

Authors:  Howard D Weiss; Gregory M Pontone
Journal:  Neurol Clin Pract       Date:  2019-08

6.  Sniffing Out Cognitive Decline in Patients with and without Evidence of Dopaminergic Deficit.

Authors:  Francesca V Lopez; Brittany Y Rohl; Aparna Wagle-Shukla; Dawn Bowers
Journal:  Clin Park Relat Disord       Date:  2019-10-17

7.  Anxiety in Parkinson's Disease: Correlation with Depression and Quality of Life.

Authors:  Ankush Upneja; Birinder S Paul; Dinesh Jain; Rupesh Choudhary; Gunchan Paul
Journal:  J Neurosci Rural Pract       Date:  2021-03-24

8.  Cognitive Function in Parkinson's Disease Patients with and without Anxiety.

Authors:  K A Ehgoetz Martens; J Y Y Szeto; A J Muller; J M Hall; M Gilat; C C Walton; S J G Lewis
Journal:  Neurol Res Int       Date:  2016-10-09

9.  White Matter Tract Alterations in Drug-Naïve Parkinson's Disease Patients With Impulse Control Disorders.

Authors:  Mahtab Mojtahed Zadeh; Amir Ashraf-Ganjouei; Farzaneh Ghazi Sherbaf; Maryam Haghshomar; Mohammad Hadi Aarabi
Journal:  Front Neurol       Date:  2018-03-20       Impact factor: 4.003

10.  Mindfulness for Motor and Nonmotor Dysfunctions in Parkinson's Disease.

Authors:  Nadeeka N W Dissanayaka; Farah Idu Jion; Nancy A Pachana; John D O'Sullivan; Rodney Marsh; Gerard J Byrne; Paul Harnett
Journal:  Parkinsons Dis       Date:  2016-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.